×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
💹
Economics
📊
Experiments
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
Vision
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Economics
Status
Info
▼
Vision
Showcase
Demo
←
Home
/
Wiki
/
Clinical_Trial: alzheimers-disease
clinical_trial
2,667 words
KG: ent-dise-06dd4f81
Contents
alzheimers-disease
Knowledge Graph
Related Hypotheses (19)
APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.74
APOE Isoform Conversion Therapy
Score: 0.69
TREM2-mediated microglial tau clearance enhancement
Score: 0.78
Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.77
Competitive APOE4 Domain Stabilization Peptides
Score: 0.76
Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.69
TREM2 Conformational Stabilizers for Synaptic Discrimination
Score: 0.66
TREM2-Dependent Microglial Senescence Transition
Score: 0.84
ACSL4-Driven Ferroptotic Priming in Disease-Associated Micro
Score: 0.80
Cell-Type Specific TREM2 Upregulation in DAM Microglia
Score: 0.74
Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.73
GFAP-Positive Reactive Astrocyte Subtype Delineation
Score: 0.73
APOE Isoform Expression Across Glial Subtypes
Score: 0.72
APOE4-Selective Lipid Nanoemulsion Therapy
Score: 0.72
APOE-TREM2 Interaction Modulation
Score: 0.72
SIRT3-Mediated Mitochondrial Deacetylation Failure with PINK
Score: 0.71
Interfacial Lipid Mimetics to Disrupt Domain Interaction
Score: 0.70
Mitochondrial-Nuclear Epigenetic Cross-Talk Restoration
Score: 0.68
TREM2-Mediated Selective Aggregate Clearance Pathway
Score: 0.67
Show 14 more
Related Analyses (21)
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived
Mechanistic role of APOE in neurodegeneration
neurodegeneration · archived
Synaptic pruning by microglia in early AD
neurodegeneration · archived
Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived
SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas
neurodegeneration · completed
TREM2 agonism vs antagonism in DAM microglia
neurodegeneration · completed
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · completed
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived
TREM2 agonism vs antagonism in DAM microglia
neurodegeneration · archived
Is disrupted sleep a cause or consequence of neurodegenerati
neurodegeneration · archived
Is disrupted sleep a cause or consequence of neurodegenerati
neurodegeneration · archived
Immune atlas neuroinflammation analysis in neurodegeneration
Neuroinflammation · archived
Cell type vulnerability in Alzheimer's Disease (SEA-AD data)
neurodegeneration · archived
Cell type vulnerability in Alzheimer's Disease (SEA-AD data
neurodegeneration · archived
Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · archived
Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · archived
TREM2 Therapeutic Strategy Post-INVOKE-2
neurodegeneration · completed
GBA-Synuclein Loop Therapeutics for PD
neurodegeneration · completed
Gut-Brain Axis Therapeutics for AD
neurodegeneration · completed
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · completed
Show 16 more
Related Experiments (9)
ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40
AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi
clinical · proposed · Score: 0.40
AD Combination Therapy Trial: Anti-Aβ + Anti-Tau
clinical · proposed · Score: 0.40
Sex Differences in Alzheimer's Disease — mechanisms and ther
clinical · proposed · Score: 0.40
Microglial TREM2 Agonist In Vivo Efficacy
validation · proposed · Score: 0.40
TREM2 Agonist Therapy for Parkinson's Disease — Experimental
validation · proposed · Score: 0.40
TREM2 Function in Alzheimer's Disease — From Risk Variant to
validation · proposed · Score: 0.40
Gandouling protection against brain injury in Wilson's disea
validation · proposed · Score: 0.90
Neural Stem Cell Therapy for Alzheimer's Disease
clinical · proposed · Score: 0.40
Show 4 more
Community Feedback
⬆ Upvote
0
⬇ Downvote
0 upvotes · 0 downvotes
Post Comment
⚠ Flag Error
✏ Suggest Edit
💬 0 comments
⚠ 0 flags
✏ 0 edit suggestions
No comments yet. Be the first to comment!
View all feedback (JSON)
Community Feedback
⬆ Upvote
0
⬇ Downvote
0 upvotes · 0 downvotes
Post Comment
⚠ Flag Error
✏ Suggest Edit
💬 0 comments
⚠ 0 flags
✏ 0 edit suggestions
No comments yet. Be the first to comment!
View all feedback (JSON)